Residency · Los Angeles, CA
Sponsored by Cedars-Sinai Medical Center
Neuroinvasion of SARS-CoV-2 in human and mouse brain.
The Journal of experimental medicine · 2021 · 828 citations · Ce Zhang
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
European journal of neurology · 2021 · 436 citations · Richard Lewis
Dementia Prevention and Treatment: A Narrative Review.
JAMA internal medicine · 2024 · 154 citations · Sarah Kremen
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
Journal of the peripheral nervous system : JPNS · 2021 · 372 citations · Richard Lewis
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
European journal of neurology · 2023 · 181 citations · Richard Lewis
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
The Lancet. Neurology · 2024 · 126 citations · Yvette Bordelon
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Neurology · 2024 · 95 citations · Richard Lewis
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Brain : a journal of neurology · 2024 · 89 citations · Elliot Hogg, Michele Tagliati